AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,000 | -95.3% | 84,146 | -85.2% | 0.00% | – |
Q4 2021 | $1,286,000 | +137.3% | 569,540 | +202.4% | 0.00% | – |
Q3 2021 | $542,000 | -15.6% | 188,357 | +11.3% | 0.00% | – |
Q2 2021 | $642,000 | -20.1% | 169,276 | -28.6% | 0.00% | – |
Q1 2021 | $804,000 | +75.5% | 237,218 | +44.8% | 0.00% | – |
Q4 2020 | $458,000 | -1.1% | 163,792 | -11.2% | 0.00% | – |
Q3 2020 | $463,000 | -75.0% | 184,493 | +35.4% | 0.00% | -100.0% |
Q2 2020 | $1,850,000 | +67.9% | 136,254 | -6.3% | 0.00% | 0.0% |
Q1 2020 | $1,102,000 | +1.0% | 145,357 | -15.8% | 0.00% | 0.0% |
Q4 2019 | $1,091,000 | +122.2% | 172,681 | +37.9% | 0.00% | – |
Q3 2019 | $491,000 | -25.0% | 125,179 | -7.4% | 0.00% | – |
Q2 2019 | $655,000 | -28.5% | 135,194 | +20.9% | 0.00% | -100.0% |
Q1 2019 | $916,000 | +1507.0% | 111,782 | +993.3% | 0.00% | – |
Q4 2018 | $57,000 | -93.2% | 10,224 | -89.2% | 0.00% | -100.0% |
Q3 2018 | $839,000 | +466.9% | 95,045 | +542.0% | 0.00% | – |
Q2 2018 | $148,000 | -50.0% | 14,805 | -52.5% | 0.00% | – |
Q1 2018 | $296,000 | +10.4% | 31,145 | +73.2% | 0.00% | – |
Q4 2017 | $268,000 | +793.3% | 17,984 | +1046.9% | 0.00% | – |
Q3 2017 | $30,000 | -84.9% | 1,568 | -88.7% | 0.00% | – |
Q2 2017 | $199,000 | +2111.1% | 13,898 | +1482.9% | 0.00% | – |
Q1 2017 | $9,000 | -79.1% | 878 | -78.3% | 0.00% | – |
Q4 2016 | $43,000 | +1333.3% | 4,052 | +1064.4% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 348 | -29.4% | 0.00% | – |
Q2 2016 | $4,000 | +100.0% | 493 | +155.4% | 0.00% | – |
Q1 2016 | $2,000 | -66.7% | 193 | -58.0% | 0.00% | – |
Q4 2015 | $6,000 | -92.0% | 459 | -94.5% | 0.00% | – |
Q3 2015 | $75,000 | +1150.0% | 8,377 | +1501.7% | 0.00% | – |
Q2 2015 | $6,000 | +20.0% | 523 | +10.3% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 474 | +6.5% | 0.00% | – |
Q4 2014 | $4,000 | +100.0% | 445 | +449.4% | 0.00% | – |
Q3 2014 | $2,000 | -97.0% | 81 | -96.7% | 0.00% | – |
Q2 2014 | $67,000 | – | 2,481 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |